Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05906602 · ClinicalTrials.gov registry record · NA
Motor and Neurophysiological Changes After Ischemic Conditioning in Individuals With Stroke
A NA study, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT05906602 is a NA study that has completed, run by University of Illinois at Chicago. The registered enrollment target is 20 participants.
The verdict
NCT05906602, a NA study, has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to test ischemic conditioning (blood flow restriction) as a neuromodulatory technique to improve gait function in stroke. Neuromodulation is emerging as a promising adjunct strategy to facilitate changes in brain activity and improve motor behavior following a neurological injury such as stroke. The main questions this trial aims to answer are: * Can ischemic conditioning produce neuromodulatory changes in the lower limb primary motor cortex? * Can ischemic conditioning be used as a neuromodulatory technique to improve strength and motor control in individuals with stroke when compared to sham ischemic conditioning? Participants will take part in two sessions of ischemic conditioning where a cuff (similar to ones that measure blood pressure) will be placed around the thigh and inflated to one of two blood flow restriction pressures (real ischemic conditioning (real IC) and sham ischemic conditioning (sham IC)). Each participant will experience measures of brain activity and motor behavior testing before and after both sessions (real IC and sham IC). Researchers will investigate ischemic conditioning as neuromodulation modality in stroke to see if ischemic conditioning can produce beneficial changes in brain activity and improvements on subsequent motor behavior tasks.
Interventions
- DEVICE Real Ischemic Conditioning
- DEVICE Sham Ischemic Conditioning
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-05-20 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05906602
The ClinicalTrials.gov registry entry for NCT05906602 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Real Ischemic Conditioning is the first listed.
NCT05906602 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05906602 about?
NCT05906602 is a clinical study titled "Motor and Neurophysiological Changes After Ischemic Conditioning in Individuals With Stroke". The goal of this clinical trial is to test ischemic conditioning (blood flow restriction) as a neuromodulatory technique to improve gait function in stroke. Neuromodulation is emerging as a promising adjunct strategy to facilitate changes in brain activity and improve motor behavior following a neur...
What is the current status of trial NCT05906602?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2024-05-20. Estimated completion is 2025-12-31.
What interventions are being tested in trial NCT05906602?
The interventions under investigation include: Real Ischemic Conditioning (DEVICE), Sham Ischemic Conditioning (DEVICE).
Who is sponsoring clinical trial NCT05906602?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.